BONE MARROW TRANSPLANT - AUTOLOGOUS OR ALLOGENEIC

Clinical trials for BONE MARROW TRANSPLANT - AUTOLOGOUS OR ALLOGENEIC explained in plain language.

Never miss a new study

Get alerted when new BONE MARROW TRANSPLANT - AUTOLOGOUS OR ALLOGENEIC trials appear

Sign up with your email to follow new studies for BONE MARROW TRANSPLANT - AUTOLOGOUS OR ALLOGENEIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a common vaccine protect the most vulnerable?

⭐️ VACCINE ⭐️ Not yet recruiting

This study is checking if the RSV vaccine Abrysvo can trigger a protective immune response in adults with blood cancers who have had a stem cell transplant or CAR-T therapy. Researchers will measure antibody levels in the blood before the shot and again four weeks and six months …

Matched conditions: BONE MARROW TRANSPLANT - AUTOLOGOUS OR ALLOGENEIC

Phase: PHASE4 • Sponsor: The Cooper Health System • Aim: ⭐️ VACCINE ⭐️

Last updated Mar 11, 2026 14:53 UTC

BONE MARROW TRANSPLANT - AUTOLOGOUS OR ALLOGENEIC

Get alerted when new BONE MARROW TRANSPLANT - AUTOLOGOUS OR ALLOGENEIC trials appear

Can a common vaccine protect the most vulnerable?